Investigation of Underlying Reasons of Factor VIII Deficiency in Haemophilia A Patients with Undetectable Mutations in the Factor VIII Gene.

Blood ◽  
2006 ◽  
Vol 108 (11) ◽  
pp. 1042-1042
Author(s):  
Osman El-Maarri ◽  
Jörg Schröder ◽  
Claudia Klein ◽  
Rainer Schwaab ◽  
Anne Goodeve ◽  
...  

Abstract Haemophilia A (HA) is an X-linked bleeding disorder caused by heterogeneous mutations in the coagulation factor VIII (F8) gene. Despite applying sensitive methods for mutation detection, and after excluding the inversions mutations a causative mutation is not identified in F8 gene in about 2,5% of severe HA patients (53 patients out of 2350 German patients). Analysis of mRNA from a small group of such (German) patients has excluded mutations deep in the introns that may affect normal splicing or mechanisms causing some unknown rearrangements of the F8 gene as the cause of HA. Among this group, in one patient no F8 mRNA was detected. Using two common polymorphisms in F8 exon 14, we were able to show that the same allele shared by the patient, his mother and his sister was not detected by reverse transcription PCR (RT-PCR) from total blood mRNA. These findings strongly suggest that the cause of HA in this patient is either absence or rapid degradation of the F8 mRNA which points to a novel mechanism leading to HA. To further investigate the cause of Hemophilia A in these patients an international multi-center study was established. The aim of this study to assemble a large collection of such families that could provide clues for novel factors/mechanisims that are important for the F8 molecule biogenesis and protein regulation as well as F8 expression. This multi-center study is therefore suposed to identify novel mechanisms causing HA.

2010 ◽  
Vol 30 (S 01) ◽  
pp. S150-S152
Author(s):  
G. Jiménez-Cruz ◽  
M. Mendez ◽  
P. Chaverri ◽  
P. Alvarado ◽  
W. Schröder ◽  
...  

SummaryHaemophilia A (HA) is X-chromosome linked bleeding disorders caused by deficiency of the coagulation factor VIII (FVIII). It is caused by FVIII gene intron 22 inversion (Inv22) in approximately 45% and by intron 1 inversion (Inv1) in 5% of the patients. Both inversions occur as a result of intrachromosomal recombination between homologous regions, in intron 1 or 22 and their extragenic copy located telomeric to the FVIII gene. The aim of this study was to analyze the presence of these mutations in 25 HA Costa Rican families. Patients, methods: We studied 34 HA patients and 110 unrelated obligate members and possible carriers for the presence of Inv22or Inv1. Standard analyses of the factor VIII gene were used incl. Southern blot and long-range polymerase chain reaction for inversion analysis. Results: We found altered Inv22 restriction profiles in 21 patients and 37 carriers. It was found type 1 and type 2 of the inversion of Inv22. During the screening for Inv1 among the HA patient, who were Inv22 negative, we did not found this mutation. Discussion: Our data highlight the importance of the analysis of Inv22 for their association with development of inhibitors in the HA patients and we are continuous searching of Inv1 mutation. This knowledge represents a step for genetic counseling and prevention of the inhibitor development.


2018 ◽  
Vol 18 (1) ◽  
Author(s):  
S. K. Nissen ◽  
A. L. Laursen ◽  
L. H. Poulsen ◽  
T. H. Mogensen

1991 ◽  
Vol 87 (1) ◽  
pp. 99-100
Author(s):  
David S. Millar ◽  
Peter J. Green ◽  
Barbara Zoll ◽  
Vijay V. Kakkar ◽  
David N. Cooper

Haemophilia ◽  
2018 ◽  
Vol 24 (3) ◽  
pp. e157-e160 ◽  
Author(s):  
S. H. Mousavi ◽  
S. A. Mesbah-Namin ◽  
N. Rezaie ◽  
S. Zeinali

2001 ◽  
Vol 85 (04) ◽  
pp. 577-579 ◽  
Author(s):  
J. Oldenburg

SummaryHaemophilia A is a X-linked recessive bleeding disorder caused by deficiency or absence of coagulation factor VIII (FVIII) due to heterogeneous defects in the FVIII gene. The large size of the FVIII gene (26 exons spanning 186 kb) has hampered mutation analysis for many years. In 1991 the first systematic analysis of the complete coding region of the FVIII gene was performed by Higuchi et al. using Denaturing Gradient Gel Electrophoresis (DGGE) as a mutation screening method (1, 2). Notably, the causative mutation was not found in about half of the severely affected patients (1). This mystery was solved in 1993, when the intron 22 inversion was discovered (3, 4) that accounts for about 50% of the severe haemophilia A cases. The inversion mutation can be easily detected by Southern Blot. A recently described PCR-based method is more sophisticated, however once established, it allows rapid and convenient detection of the intron 22 inversion (5).


Sign in / Sign up

Export Citation Format

Share Document